Flexible Colonoscope Assisted Hybrid Transanal Total Mesorectal Resection (taTME)
1 other identifier
observational
5
1 country
1
Brief Summary
The investigators propose to use flexible endoscopy combined with transanal total mesorectal resection to further reduce anal injury.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Aug 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 24, 2022
CompletedFirst Submitted
Initial submission to the registry
April 17, 2024
CompletedFirst Posted
Study publicly available on registry
April 24, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 24, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 24, 2025
CompletedApril 24, 2024
April 1, 2024
3 years
April 17, 2024
April 23, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Success rate of operation
Whether it is necessary to switch to other surgical methods
1 years after the surgery
Study Arms (1)
Flexible colonoscope assisted taTME group
Flexible colonoscope assisted hybrid transanal total mesorectal resection (taTME) group
Interventions
Endoscopic pursestring suture (EPSS) was performed at the distance from 1cm to the inferior edge of the tumor by a double-channel flexible colonoscope. An endoloop was inserted through one channel. Meanwhile, the endoclips was inserted through the other channel one by one to fix the endoloop around the rectal wall. And then the endoloop was tightened slowly. After completing the routine lavage lumen, a full-thickness, circumferential dissection was performed by flexible colonoscope following taTME surgical principle until it converged with the laparoscopy group.
Eligibility Criteria
All patients suitable for transanal endoscopic surgery
You may qualify if:
- Age between 18 and 80 years old
- Confirmed rectal adenocarcinoma cancer pathologically
- tumor location ≦ 12 cm from the anal margin
- Willing and able to provide written informed consent for participation in this study
You may not qualify if:
- distant metastasis before surgery
- more than one colorectal tumor at diagnosis
- familial adenomatous polyposis
- recurrent rectal cancer
- undergo transanal minimally invasive surgery
- undergo palliative treatment
- undergo emergency surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of colorectal surgery, the Sixth Affiliated Hospital, Sun Yat-Sen University
Guangzhou, Guangdong, 510000, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Flexible Colonoscope Assisted Hybrid Transanal Total Mesorectal Resection (taTME)
Study Record Dates
First Submitted
April 17, 2024
First Posted
April 24, 2024
Study Start
August 24, 2022
Primary Completion
August 24, 2025
Study Completion
August 24, 2025
Last Updated
April 24, 2024
Record last verified: 2024-04